The global synthetic mRNA therapeutics market size was valued at USD 2.86 billion in 2025 and is expected to reach USD 11.73 billion by 2033, at a CAGR of 19.30% during the forecast period
The market growth is largely fueled by the rapid advancements in mRNA technology platforms and increasing adoption of precision medicine approaches, along with rising investments in biotechnology and vaccine development, leading to expanded applications of synthetic mRNA therapeutics in disease treatment and prevention
Furthermore, growing prevalence of cancer, infectious diseases, and rare genetic disorders, coupled with strong clinical pipeline activity and increasing focus on personalized medicine, is establishing synthetic mRNA therapeutics as a transformative treatment modality. These converging factors are accelerating the uptake of Synthetic mRNA Therapeutics solutions, thereby significantly boosting the market growth